MRMD
Marimed Inc.
$0.07
0.00 (-1.45%)
At close · Jul 2
Market Cap
$27.15M
Shares
399,266,091
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.07
Open$0.07
Day$0.07–0.07
52W$0.06–0.23
Avg vol 30d368K
Short int16K · 0.0% float · 1.0d
Short vol8%
Last earningsMay 13, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−28% below
−
Price vs 50-day avg
−11% below
◦
RSI (14)
43 · neutral
+
MACD trend
positive
−
52-week position
2% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
−
Institutional flow
-25% holders QoQ
+
Insider flow
Net +$7.5K over 90 days · 0% sells
+
Short interest
0.00% of float · ▼ -75.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
3 holders — mid 3-yr range
Fundamentals
Strong
+
Revenue growth
+12% Y/Y
+
Gross margin
114%, contracting
−
EPS growth
−33% Y/Y
+
Free cash flow
$6.5M
−
Balance sheet
net debt $68.8M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−28% below
Bearish
Price vs 50-day avg
−11% below
Bearish
RSI (14)
43 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
2% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ
Insider flow
Accumulating
Net +$7.5K over 90 days · 0% sells
Short interest
Falling
0.00% of float · ▼ -75.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
3 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 2%
52-wk high $0
vs 200-day avg -28%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP Adjusted EBITDA non-GAAP | $3.6M | Q1 2026 | — |
| Non-GAAP Adjusted EBITDA margin non-GAAP | 9% | Q1 2026 | — |
| Non-GAAP Gross margin non-GAAP | 40% | Q1 2026 | — |
| Wholesale revenue growth | 11% | Year ended December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MRMD
this stock
Marimed Inc.
|
$27.15M | -27.7% | +11.6% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
3
- % held
- 0.2%
- Net QoQ
- -321.7K sh
- Top holder
- Canton Hathaway, LLC
Held
Float
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MRMD | -6.9% | -10.5% | -26.9% | -2.9% | -27.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -8.3% | -9.3% | -34.9% | -2.6% | -36.9% |